Benchmark Co. Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $35
Surgery Partners Price Target Maintained With a $35.00/Share by Benchmark
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Surgery Partners (SGRY)
Surgery Partners, Inc. to Release First Quarter 2025 Financial Results and Host Conference Call on May 12, 2025
Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Cuts Target Price to $25
Surgery Partners (SGRY) Receives a Hold From Barclays
Cantor Fitzgerald Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $36
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected
SA Charts: How Are M&A Deals Shaping up at the Start of 2025?
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Surgery Partners Executives Cash Out: See Who Sold Big!
Mizuho Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $28
Strong Financial Performance and Strategic Positioning Drive Buy Rating for Surgery Partners
The Modern Facelift: Leading Experts at Premier Plastic Surgery Partners Share Insights on Rapid Recovery & Remarkable Results
Surgery Partners Analyst Ratings
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating
RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $35
Surgery Partners (SGRY) Gets a Buy From RBC Capital
Surgery Partners | 10-K: FY2024 Annual Report
TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $28